Cooper Companies (NASDAQ:COO) Given Hold Rating at Needham & Company LLC

Cooper Companies (NASDAQ:COO)‘s stock had its “hold” rating reissued by investment analysts at Needham & Company LLC in a note issued to investors on Thursday, Benzinga reports.

Several other research firms have also issued reports on COO. KeyCorp initiated coverage on Cooper Companies in a report on Tuesday, February 6th. They set a “sector weight” rating on the stock. TheStreet lowered Cooper Companies from a “b-” rating to a “c” rating in a report on Thursday, February 29th. JPMorgan Chase & Co. upgraded Cooper Companies from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $100.00 to $120.00 in a report on Wednesday, March 13th. Citigroup upped their target price on Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Finally, Mizuho upped their target price on Cooper Companies from $102.50 to $115.00 and gave the stock a “buy” rating in a report on Friday, March 1st. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average target price of $109.69.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $96.60 on Thursday. The firm has a market cap of $19.20 billion, a price-to-earnings ratio of 66.05, a price-to-earnings-growth ratio of 2.45 and a beta of 0.97. The stock’s 50-day moving average is $95.71 and its 200-day moving average is $93.24. Cooper Companies has a one year low of $75.93 and a one year high of $104.07. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.86 and a quick ratio of 1.08.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, February 29th. The medical device company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. The company had revenue of $931.60 million for the quarter, compared to analyst estimates of $915.93 million. Cooper Companies had a return on equity of 8.79% and a net margin of 7.93%. The company’s quarterly revenue was up 8.5% compared to the same quarter last year. During the same period in the previous year, the company posted $2.90 earnings per share. Equities analysts predict that Cooper Companies will post 3.5 earnings per share for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In other news, CAO Agostino Ricupati sold 54,724 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $100.89, for a total value of $5,521,104.36. Following the transaction, the chief accounting officer now owns 5,081 shares of the company’s stock, valued at $512,622.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, Director Gary S. Petersmeyer sold 1,000 shares of the stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $103.51, for a total transaction of $103,510.00. Following the sale, the director now owns 5,668 shares of the company’s stock, valued at $586,694.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Agostino Ricupati sold 54,724 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $100.89, for a total value of $5,521,104.36. Following the sale, the chief accounting officer now directly owns 5,081 shares in the company, valued at approximately $512,622.09. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Cooper Companies

Large investors have recently modified their holdings of the business. Dimensional Fund Advisors LP boosted its holdings in shares of Cooper Companies by 8.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 297,675 shares of the medical device company’s stock valued at $112,656,000 after purchasing an additional 22,884 shares in the last quarter. Quest Partners LLC bought a new position in shares of Cooper Companies in the 4th quarter valued at $805,000. Principal Securities Inc. bought a new position in shares of Cooper Companies in the 4th quarter valued at $149,000. Janney Montgomery Scott LLC lifted its stake in shares of Cooper Companies by 1.0% in the 4th quarter. Janney Montgomery Scott LLC now owns 24,319 shares of the medical device company’s stock valued at $9,204,000 after acquiring an additional 241 shares during the last quarter. Finally, Simplicity Wealth LLC bought a new position in shares of Cooper Companies in the 1st quarter valued at $544,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.